Concepedia

Author

Shuning Xu

Zhengzhou University

Also Known As

Qingqing Ge, S N Xu, Shu-Ning Xu, Shu-ning XU, Shu-ning Xu, Shuning Xu, Shu‐ning Xu, Shu‑Ning Xu, Xu, Shuning

80

Publications

800

Citations

16

H-Index

76

Concepts

All Affiliations

Zhengzhou UniversityHenan Cancer HospitalFirst Affiliated Hospital of Zhengzhou UniversitySoochow UniversityCity University of Macau
SX

About

Shuning Xu is an author at Zhengzhou University specializing in engineering, oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

7

7

208

2

Health Sciences

2

2

47

3

Business

1

1

23

4

Education

1

1

11

5

Language Studies

1

1

11

Shuning Xu

×

30

Publications

708

Citations

16

H-Index

YearCitations

Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer.

Ying Liu, Z P Ren, Long Yuan,

PubMed

2016

59

MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.

Shuai Li, Yulian Ma, Xinfang Hou,

PubMed

2015

58

Rapid in-situ composting of household food waste

Xule Zhou, Jiaqian Yang, Shuning Xu,

Process Safety and Environmental Protection

2020

58

NTIRE 2023 Image Shadow Removal Challenge Report

Florin-Alexandru Vasluianu, Tim Seizinger, Radu Timofte,

2023

43

Spectral CT-based nomogram for preoperative prediction of perineural invasion in locally advanced gastric cancer: a prospective study

Jing Li, Shuning Xu, Yi Wang,

European Radiology

2023

39

Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety.

Ying Liu, Guangsen Han, Hongle Li,

Journal of Clinical Oncology

2021

36

First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study

Ying Liu, Han Yue, Shuning Xu,

International Journal of Clinical Oncology

2015

31

miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin

Shuning Xu, Danyang Li, Tianyuan Li,

Cellular Physiology and Biochemistry

2018

29

RETRACTED: Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistance

Danyang Li, Ruixue Cui, Shuning Xu,

Drug Delivery

2020

29

PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma

Ke Li, Ying Liu, Shuning Xu,

Pathology & Oncology Research

2018

26

Page 1